Gene Therapy - Table of Contents alert Volume 19 Issue 7

TABLE OF CONTENTS Volume 19, Issue 7 (July 2012) In this issue News and Commentary Enabling Technologies Original Articles Short Communications Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you seen this article in Gene Therapy Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment T Sugiyama, M Yoneda, T Kuraishi, S Hattori, Y Inoue, H Sato and C Kai Gene Ther ¦ doi:10.1038/gt.2012.44   News and Commentary Top Silencing the FOP gene J W Lowery and V Rosen Gene Ther 2012 19: 701-702; advance online publication, December 1, 2011; 10.1038/gt.2011.190 Full Text Enabling Technologies Top Ultrasound-targeted microbubble destruction enhances naked plasmid DNA transfection in rabbit Achilles tendons in vivo L Qiu, L Zhang, L Wang, Y Jiang, Y Luo, Y Peng and L Lin Gene Ther 2012 19: 703-710; advance online publication, October 27, 2011; 10.1038/gt.2011.165 Abstract | Full Text Original Articles Top Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF K-J Choi, S-N Zhang, I-K Choi, J-S Kim and C-O Yun Gene Ther 2012 19: 711-723; advance online publication, October 13, 2011; 10.1038/gt.2011.125 Abstract | Full Text AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice T Kiyota, K L Ingraham, R J Swan, M T Jacobsen, S J Andrews and T Ikezu Gene Ther 2012 19: 724-733; advance online publication, September 15, 2011; 10.1038/gt.2011.126 Abstract | Full Text The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma E Kiyohara, K Tamai, I Katayama and Y Kaneda Gene Ther 2012 19: 734-741; advance online publication, September 8, 2011; 10.1038/gt.2011.123 Abstract | Full Text Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys R W Veneziale, N S Kishnani, J Nelson, J C Resendez, D W Frank, X-Y Cai, L Xie, C Cullen, C A Frugone, C Rosenfeld, J Hubbell, S E Maxwell, B J Sugarman, B Hutchins, D Maneval and K A Treinen Gene Ther 2012 19: 742-751; advance online publication, September 8, 2011; 10.1038/gt.2011.116 Abstract | Full Text Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene S-Y Chen, A-L Shiau, Y-T Li, Y-S Lin, C-H Lee, C-L Wu and C-R Wang Gene Ther 2012 19: 752-760; advance online publication, November 17, 2011; 10.1038/gt.2011.173 Abstract | Full Text Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein D C J Carpentier, K Vevis, A Trabalza, C Georgiadis, S M Ellison, R I Asfahani and N D Mazarakis Gene Ther 2012 19: 761-774; advance online publication, September 8, 2011; 10.1038/gt.2011.124 Abstract | Full Text Short Communications Top Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery L Li, R Wang, D Wilcox, X Zhao, J Song, X Lin, W M Kohlbrenner, S W Fesik and Y Shen Gene Ther 2012 19: 775-780; advance online publication, September 29, 2011; 10.1038/gt.2011.146 Abstract | Full Text Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva M Takahashi, T Katagiri, H Furuya and H Hohjoh Gene Ther 2012 19: 781-785; advance online publication, December 1, 2011; 10.1038/gt.2011.193 Abstract | Full Text Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting J Kaplan, F S Kaplan and E M Shore Gene Ther 2012 19: 786-790; advance online publication, October 20, 2011; 10.1038/gt.2011.152 Abstract | Full Text Advertisement Scientific Reports publishes 457 open access papers in its first year Publishing technically sound research articles, Scientific Reports is Nature Publishing Group’s fastest growing journal. Given the speed and visibility offered, no wonder 93% of our authors said that they are “likely” or “very likely” to submit again. Keep your research moving. Submit to Scientific Reports   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.